Pancreatic Market Growth

The global pancreatic cancer market is expected to grow significantly, valued at $5.84 billion by 20230, with a CAGR of 12.3%, according to Grand View Research. This growth expectation looks promising for NVCR's Option Pax as a non‑invasive treatment option.